Galena Biopharma Inc (GALE.OQ)
* Galena Biopharma-on Sept 5, unit of co and Biovascular, entered amendment of exclusive license agreement between MPI and BVI dated December 20, 2013
* Galena Biopharma and Biovascular Inc reaffirm GALE-401 partnership
Galena Biopharma Inc will pay more than $7.55 million to resolve charges it paid kickbacks to doctors to induce them to prescribe its opioid-based pain medication Abstral to patients, the U.S. Department of Justice said on Friday.
Sept 8 Galena Biopharma Inc will pay more than $7.55 million to resolve charges it paid kickbacks to doctors to induce them to prescribe its opioid-based pain medication Abstral to patients, the U.S. Department of Justice said on Friday.
* Department of Justice says "Galena Biopharma Inc to pay more than $7.55 million to resolve alleged false claims related to opioid drug"
* RXi Pharmaceuticals announces completion of enrollment of phase 2 clinical trial with samcyprone for cutaneous warts Source text for Eikon: Further company coverage:
* Galena Biopharma reports second quarter 2017 financial results
* RXi Pharmaceuticals reports second quarter 2017 financial results and recent corporate highlights
* Galena Biopharma - cannot complete by Aug 9, additional changes to June 30, 2017 form 10-q to include all necessary disclosure resulting from merger
* RXi Pharmaceuticals enters into common stock purchase agreement for up to $15.0 million
|Pfizer Inc. (PFE.N)||$35.42||-0.12|
|Kissei Pharmaceutical Co Ltd (4547.T)||¥2,874||+4.00|
|Roche Holding Ltd. (ROG.S)||CHF244.80||+1.10|
|Roche Holding Ltd. (RO.S)||CHF245.70||+1.70|
|Bayer AG (BAYGn.DE)||€109.95||-0.55|
|Bayer AG (BAYE.F)||--||--|
|Sanofi SA (SASY.PA)||€82.25||+0.73|
|GlaxoSmithKline plc (GSK.L)||1,449.50||-7.50|
|Amgen, Inc. (AMGN.OQ)||$186.27||-0.20|
|Alnylam Pharmaceuticals, Inc. (ALNY.OQ)||$75.53||-0.47|